Scienceblogtwo

The virus that causes COVID-19, SARS-CoV-2, can be precisely located using a new designed CRISPR-based technique. The extremely sensitive detector promises to make COVID-19 and other illness testing quick and simple. Researchers from Rice University and the University of Connecticut improved the CRISPR-Cas13 RNA-editing technology to increase its capability of spotting minute quantities of the SARS-CoV-2 virus in biological samples. It does this without the time-consuming RNA extraction and amplification phase required in gold-standard PCR testing, which is a major advantage. Comparing the novel platform to PCR testing, it was quite successful. In reality, tests on clinical samples obtained directly from nose swabs revealed 10 out of 11 positives and no false positives for the virus. The researchers demonstrated how their method can detect SARS-CoV-2 in quantities as low as attomolar (10–18). The research will be released in the journal Nature Chemical Biology today, September 22, 2022...

A group of Mount Sinai researchers have created a high-resolution crystal structure of an enzyme required for SARS-CoV-2, the virus that causes COVID-19, to survive. The discovery may aid in the development of critically needed new antivirals to fight coronaviruses both now and in the future. The RNA methyltransferase domain, a crucial component of the enzyme known as nsp14, is present. The three-dimensional crystal structure of this region has defied prior attempts by the scientific community to characterize it. The novel procedure is described in a publication that was released in Nature Structural & Molecular Biology's online edition on September 8. Aneel Aggarwal, PhD, a senior author on the paper, notes that being able to see the methyltransferase domain of nsp14 in high resolution provides insights into how to build tiny compounds that fit into its active site and thereby hinder its crucial chemistry. At Mount Sinai's Icahn School of Medicine, he has the title of Prof...

Vaccination producer CanSino stated in a news release on Sunday that just one inhale of a vaccine mist can offer powerful immune defense against COVID-19 (Sept. 4). The first substitute for the injectable vaccines used during the pandemic, a COVID-19 vaccine mist has been given the go-ahead by Chinese regulators for use as a booster dosage. The inhaled vaccination is made of the same components as the injections administered in China, but a nebulizer transforms the liquid vaccine into an aerosol spray.                                                                                                         CanSino's formulation incorporates bits of genetic material so the body can recognize the virus, much like the COVID-19 vacc...

It's ironic that certain immunizations require additional "boosters." Adjuvants, which help vaccines elicit a more powerful immune response and better prepare the body to combat pathogens, can be added to vaccines. According to research, an additive increased the immune response to an experimental COVID-19 injection in mice by 25 times more than the vaccination alone. A new publication detailing the discovery was released in the ACS Infectious Diseases journal today, August 31, 2022. Some vaccinations contain an adjuvant, which aids in the development of a stronger immune response in recipients. In other words, adjuvants increase the effectiveness of immunizations. Despite the use of cutting-edge mRNA genetic technology in the first COVID-19 injections approved in the U.S., the tried-and-true method of employing pathogen proteins can result in vaccinations that are less expensive to develop and simpler to store. Only one protein-based vaccination against SARS-CoV-2 has be...